ARTICLE | Politics & Policy
BIO elects Maraganore as chairman
June 20, 2017 3:33 PM UTC
BIO elected John Maraganore chairman for its 2017-18 term. He is CEO of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY).
Maraganore succeeds Ron Cohen in the role. Cohen, who is president and CEO of Acorda Therapeutics Inc. (NASDAQ:ACOR), had been chairman since 2015...